Abstract
It is now well-established that the interleukin (IL)-1 family of cytokines initiates the acute immune response and, at the same time and in order to adapt the organism to the stress of inflammation, activates the two stress axes, i.e., the hypothalamuspituitary-adrenal (HPA) and the sympathetic. The initiation of the stress response by the IL-1 cytokines takes place centrally, at the central nervous system. There, the IL-1 cytokines stimulate the production of corticotropin-releasing hormone (CRH) in the parvocellular part of the paraventricular hypothalamic nucleus and the production of norepinephrine in hypothalamus and locus ceruleus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bartfai T, Schultzberg M. Cytokines in neuronal cell types. Neurochem Int 1993; 22: 435–444.
Mazzocchi G, Malendowicz LK, Markowska A, Nussdorfer GG. Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivities in the rat adrenal gland. Mol Cell Neurosci 1994; 5: 345–349.
Nussdorfer GG, Mazzocchi G. Immune-endocrine interactions in the mammalian adrenal gland: facts and hypotheses. Int Rev Cytol 1998; 183: 143–184.
Carter DB, Deibel MR, Dunn CJ, Tomich C-S, Laborte AL, Slighton JL, et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990; 344: 633–638.
Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer T, Hannum CH, et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990; 343: 341–346.
Haskill S, Martin G, Van Le L, Morris J, Peace A, Bigler CF, et al. cDNA cloning of an intracellular form of the human interleukin-1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA 1991; 88: 3681–3685.
Krzesicki RF, Hatfield CA, Bienkowski MJ, Mcguide JC, Winterrowd GE, Chapman DL, et al. Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts. J Immunol 1993; 150: 4008–4018.
Tada M, Dierens A-C, Desbaillets I, Jaufeerlly R, Hamou M-F, De Tribolet N. Production of interleukin-1 receptor antagonist by human glioblastoma cells in vitro and in vivo. J Neuroimmunol 50: 187–194.
Schultzberg M, Andersson C, Unden A, Troye-Blomberg M, Svenson SB, Bartfai T. Interleukin-1 in adrenal chromaffin cells. Neuroscience 1989; 30: 805–810.
Naito Y, Fukata J, Nakaishi S, Nakai Y, Hirai Y, Tamai S, et al. Chronic effects of interleukin-1 on hypothalamus, pituitary, and adrenal glands in rat. Neuroendocrinology 1990; 51: 637–641.
Alheim K, Andersson C, Tingsborg S, Ziolkowska M, Schultzberg M, Bartfai T. Interleukin 1 expression is inducible by nerve growth factor in PC12 pheochromocytoma cells. Proc Natl Acad Sci USA 1991; 88: 9301–9306.
Li XM, Jourio AV, Boulton AA. Induction of aromatic L-amino acid decarboxylase mRNA by interleukin-lbeta and prostaglandin E2 in PC12 cells. Neurochem Res 1994; 19: 591–595.
Yanagihara N, Minami K, Shirakawa F, Uezono Y, Kobayashi H, Eto S, et al. Stimulatory effect of IL-lb on catecholamine secretion from cultured bovine adrenal medullary cells. Biochem Biophys Res Corn 1994; 198: 81–87.
Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, et al. Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci 1993; 13: 3574–3581.
Gonzalez-Hernandez JA, Bornstein M, Geschwend JE, Adler G, Scherbaum WA. Macrophages within the human adrenal gland. Morphological data for a possible local immune-neuroendocrine interaction. Cell Tissue Res 1994; 278: 201–205.
Gonzalez-Hernandez JA, Bornstein SR, Ehrhart-Bornstein M, Gschwend JE, Gwosdow A, Jirikowski G, et al. IL-1 is expressed in human adrenal gland in vivo. Possible role in a local immune-adrenal axis. Clin Exp Immunol 1995; 99: 137–141.
Wan DC, Scanlon D, Choi CL, Bunn SJ, Howe PR, Livett BG. Co-localization of RNAs coding for phenylethanolamine N-methyltransferase and proenkephalin A in bovine and ovine adrenals. J Auton Nerv Syst 1989; 26: 231–240.
Margioris AN. Opioids in neural and non-neural tissues. Trends Endocrinol Metab 1993; 4: 163–168.
Cahill AL, Eertmoed AL, Mangoura D, Perlman RL. Differential regulation of phenylethanolamine N-methyltransferase expression in two distinct subpopulations of bovine chromaffin cells. J Neurochem 1996; 67: 1217–1224.
Andersson C, Svenson SB, Van Deventer S, Cerami A, Bartfai T. Interleukin-lalpha expression is inducible by cholinergic stimulation in the rat adrenal gland. Neuroscience 1992; 47: 481–485.
Nobel CS, Schultzberg M. Induction of interleukin-1 beta mRNA and enkephalin mRNA in the rat adrenal gland by lipopolysaccharides studied by in situ hybridization histochemistry. Neuroimmunomodulation 1995; 2: 61–73.
Schultzberg M, Svenson SB, Unden A, Bartfai T. Interleukin-1-like immunoreactivity in peripheral tissues. J Neuroscience Res 1987; 18: 184–189.
Schultzberg M, Tingsboro S, Nobel S, Lundkvist J, Svenson SB, Simoncsits A, et al. Interleukin-1 receptor antagonist protein and mRNA in the rat adrenal gland. J Interf Cytokine Res 1995; 15: 721–729.
Bornstein SR, Erhrart-Bornstein M, Gonzalez-Hernandez JA, Schroder S, Scherbaum WA. Expression of interleukin-1 in human pheochromocytoma. J Endocrinol Invest 1996; 19: 693–698.
Venihaki M, Gravanis A, Margions AN. KAT45 human pheochromocytoma cell line. A new model for the in vitro study of neuro-immunohormonal interactions. Ann NY Acad Sci 1998; 840: 425–433.
Alheim K, McDowell TL, Symons JA, Duff GW, Bartfai T. An AP-1 site is involved in the NGF induction of IL-1 alpha in PC12 cells. Neurochem Int 1996; 29: 487–496.
Emoto H, Yokoo H, Yoshida M, Tanaka M. Corticotropin-releasing factor enhances noradrenaline release in the rat hypothalamus assessed by intracerebral microdialysis. Brain Research 1993; 601: 286289.
Lavicky J, Dunn AJ. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 1993; 60: 60 2612.
Lee EHY, Chang SY, Chen AYJ. CRH facilitates NE release from the hippocampus: a microdialysis study. Neuroscience Res 1994; 19: 327–330.
Smagin GN, Swirgiel AH, Dunn AJ. Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex. Brain Res Bull 1995; 36: 71–76.
Olianas MC, Onali P. Corticotropin-releasing factor activates tyrosine hydroxylase in rat and mouse striatal homogenates. Eur J Pharmacol 1998; 150: 389–392.
Olianas MC, Onali P. Stimulation of synaptosomal dopamine synthesis by corticotropin-releasing factor in rat striatum: role of Ca’-dependent mechanisms. Europ J Pharmacol 1989; 166: 165–174.
Posener JA, Schidkraut JJ, Williams GH, Gleason RE, Salomon MS, Mecheri G, et al. Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man. Biol Psychiatry 1994; 36: 616–621.
Valentino RJ, Foote SL, Aston-Jones G. Corticotropin-releasing factor activates noradrenergic neurons in the locus coeruleus. Brain Res 1983; 270: 363–367.
Valentino RJ, Wehby RG. Corticotropin-releasing factor: Evidence for a neurotransmitter role in the locus coeruleus during hemodynamic stress. Neuroendocrinology 1988; 48: 674–677.
Valentino RJ, Page ME, Curtis AL. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res 1991; 555: 25–34.
Valentino RJ, Page ME, Van Bockstaele E, Aston-Jones G. Corticotropin-releasing factor innervation of the locus-coeruleus region: distribution of fibers and source of input. Neuroscience 1992; 48: 689–705.
Suda T, Tomori N, Tozawa F, Mouri T, Demura H, Schizume K. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. J Clin Endocrinol Metab 1984; 59: 861–867.
Suda T, Tomori N, Yajima F, Odagiri E, Demura H, Shizume K. Characterization of immunoreactive corticotropin and corticotropin-releasing factor in human adrenal and ovarian tumors. Act Endocrinol (Copenh) 1986; 111: 546–552.
Nicholson WE, DeCherney GS, Jackson RV, Orth DN. Pituitary and hypothalamic hormones in normal and neoplastic adrenal medulla: biologically active corticotropin-releasing hormone and corticotropin. Regul Pep 1987; 18: 173–188.
Usui T, Nakai Y, Tsukada T, Jingami H, Takahashi H, Fukata J, et al. Expression of the adrenocorticotropin-releasing hormone precursor gene in placenta and other nonhypothalamic tissues in man. Mol Endocrinol 1988; 2: 871–875.
Merchenthaler I. Corticotropin-releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 1984; 5: 53–69.
Bagdy G, Calogero AE, Szemeredi K, Chrousos GP, Gold PW. Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH. Regul Pept 1990; 31: 83–92.
Venihaki M, Gravanis A, Margions AN. Comparative study between normal rat chromaffin and PC12 ratpheochromocytoma cells: production and effects of corticotropin-releasing hormone. Endocrinology 1997; 138: 698–704.
Hashimoto K, Murakami K, Hattori T, Niimi M, Fujimo K, Ota Z. Corticotropin-releasing factor (CRF)-like immunoreactivity in the adrenal medulla. Peptides 1984; 5: 707–712.
Edwards AV, Jones CT. Secretion of corticotropin releasing factor from the adrenal during splachnic nerve stimulation in conscious calves. J Physiol (London) 1988; 40: 89–100.
Minamino N, Uehara A, Arimura A. Biological and immunological characterization of corticotropinreleasing activity in bovine adrenal medulla. Peptides 1988; 9: 37–45.
Bruhn TO, Engeland WC, Anthony ELP, Gann DS, Jackson IDM. Corticotropin-releasing factor in the dog adrenal medulla is secreted in response to hemorrhage. Endocrinology 1987a; 120: 25–33.
Bruhn TO, Engeland WC, Anthony ELP, Gann DS, Jackson IDM. Corticotropin-releasing factor in the adrenal medulla. Ann NY Acad Sci 1987b; 512: 115–128.
Udelsman R, Harwood JP, Milian MA, Chrousos GP, Golstein DS, Zimlichman R, et al. Functional corticotropin-releasing factor receptors in the primate peripheral sympathetic nervous system. Nature 1986; 6049: 147–150.
Aguilera G, Milian MA, Hauger RL, Catt KJ. Corticotropin-releasing factor receptors: distribution and regulation in brain, pituitary and peripheral tissues. Ann NY Acad Sci 1987; 512: 48–66.
Sasaki A, Yumita S, Kimura S, Miura Y, Yoshinaga K. Immunoreactive corticotropin-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extra-adrenal pheochromocytoma. J Clin Endocrinol Metab 1990; 70: 996–999.
O’Brien T, Young WF, Davila DG, Scheithauer BW, Kovacs K, Hovath E, et al. Cushing’s syndrome associated with ectopic production of corticotropin-releasing hormone, corticotropin and vasopressin by pheochromocytoma. Clin Endocrinol Oxf 1992; 37: 460–467.
Tsuchihashi T, Yamaguchi K, Abe K, Yanihara N, Saito S. Production of immunoreactive corticotropinreleasing hormone in various neuroendocrine tumors. Jpn J Clin Oncol 1992; 22: 232–237.
Saeger W, Reincke M, Scholz GH, Ludecke DK. Ectopic ACTH- or CRH-secreting tumors in Cushing’s syndrome. Zentralbi Pathol 1993; 139: 157–163.
Liu J, Heikkila P, Voutilainen R, Karonen SL, Kahri AI. Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone; regulation by glucocorticoids and nerve growth factor. Eur J Endocrinol 1994; 131: 221–228.
Venihaki M, Ain K, Dermitzaki E, Gravanis A, Margions AN. KAT45, a noradrenergic human pheochromocytoma cell line producing corticotropin-releasing hormone. Endocrinology 1998; 139: 713–722.
Berkenbosch F, Van Oers J, Del Rey A, Tilders F, Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987; 238: 524–526.
Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987; 238: 522–524.
Eskay RL, Eiden LE. Interleukin-1 alpha and tumor necrosis factor-alpha differentially regulate enkephalin, vasoactive intestinal polypeptide, neurotensin, and substance P biosynthesis in chromaffin cells. Endocrinology 1992; 130: 2252–2258.
O’Konnel NA, Kumar A, Chatzipanteli K, Mohan A, Agarwal RK, Head C, et al. Interleukin-1 regulates corticosterone secretion from the rat adrenal gland through a catecholamine-dependent and prostaglandin E2-independent mechanism. Endocrinology 1994; 135: 460–467.
Andreis PG, Neri G, Belloni AS, Mazzocchi G, Kasprzak A, Nussdorfer GG. Interleukin-1 beta enhances corticosterone secretion by acting directly on the rat adrenal gland. Endocrinology 1991; 129: 53–57.
Gwosdow AR, O’Connell NA, Spencer JA, Kumar MS, Agarwal RK, Bode HH, et al. Interleukin1-induced corticosterone release occurs by an adrenergic mechanism from rat adrenal gland. Am J Physiol 1992; 263: E461–466.
Gwosdow AR. Mechanisms of interleukin-1-induced hormone secretion from the rat adrenal gland. Endocr Res 1995; 21: 25–37.
Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, et al. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 1994; 643: 40–49.
MohanKumar PS, Quadri SK. Systemic administration of interleukin-1 stimulates norepinephrine release in the paraventricular nucleus. Life Sci 1993; 52: 1961–1967.
Terao A, Oikawa M, Saito M. Cytokine-induced change in hypothalamic norepinephrine turnover: involvement of corticotropin-releasing hormone and prostaglandins. Brain Res 1993; 622: 257–261.
Terao A, Oikawa M, Saito M. Tissue-specific increase in norepinephrine turnover by central interleukin1 but not by interleukin-6, in rats. Am J Physiol 1994; 266: R400 - R404.
Hurst S, Collins SM. Interleukin-1 beta modulation of norepinephrine release from rat myenteric nerves. Am J Physiol 1993; 264: G30 - G35.
Vriend CY, Zuo L, Dyck DG, Nance DM, Greenberg AH. Central administration of interleukin-1 beta increases norepinephrine turnover in the spleen. Brain Res Bull 1993; 31: 39–42.
Shimizu N, Hori T, Nakane H. An interleukin-1 beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: an in vivo microdialysis study in conscious rats. Brain Behav Immun 1994; 8: 14–23.
Sakata Y, Morimoto A, Murakami N Changes in plasma catecholamines during fever induced by bacterial endotoxin and interleukin-1 beta. Jpn J Physiol 1994; 44: 693–703.
Cunningham Jr ET, Wada E, Carter DB, Tracey DE, Battey JF, DeSouza EB. In situ histochemical localization of type 1 interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. Neurosci 1992; 12: 1101–1114.
Lujan HJ, Mathews HL, Gamelli RL, Jones SB. Human immune cells mediate catecholamine secretion from adrenal chromaffin cells. Crit Care Med 1998; 26: 1218–1224.
Jain R, Zwickler D, Hollander CS, Brand H, Saperstein A, Hutchinson B, et al. Corticotropin-releasing factor modulates the immune response to stress in the rat. Endocrinology 1991; 128: 1329–1336.
Carr DJ, Weigent DA, Blalock JE. Hormones common to the neuroendocrine and immune systems. Drug Des Deliv 1989; 4: 187–195.
Carr DJ, DeCosta BR, Jacobson AE, Rice KC, Blalock JE. Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway. J Neuroimmunol 1990; 28: 53–61.
Thomas HA, Ling N, Wei ET. CRF and related peptides as antiinflammatory agonists. Ann NY Acad Sci 1993; 697: 219–228.
Paez Pereda M, Sauer J, Perez Castro C, Finkielman S, Stalla GK, Holsboer F, et al. Corticotropinreleasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology 1995; 136: 5504–5510.
Takao T, Tojo C, Nishioka T, Hashimoto K, De Souza EB. Corticotropin-releasing factor treatment upregulates interleukin-1 receptors in the mouse pituitary: reversal by dexamethasone. Brain Res 1995; 688: 219–222.
Webster EL, Tracey DE, De Souza EB. Upregulation of interleukin-1 receptors in mouse AtT-20 pituitary tumor cells following treatment with corticotropin-releasing factor. Endocrinology 1991; 129: 2796–2798.
Singh VK. Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J Neuroimmunol 1989; 23: 257–262.
Doherty GM, Jensen JC, Buresh CM, Norton JA. Hormonal regulation of inflammatory cell cytokine transcript and bioactivity production in response to endotoxin. Cytokine 1992; 4: 55–62.
Lininio J, Gold PW, Wong ML. A molecular mechanism for stress-induced alterations in susceptibility to disease. Lancet 1995; 346: 104–106.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Margioris, A.N., Dermitzaki, E., Venihaki, M., Gravanis, A. (2001). Interleukin (IL)-1 Family of Cytokines and Corticotropin-Releasing Hormone (CRH) in the Adrenal Gland. In: Margioris, A.N., Chrousos, G.P. (eds) Adrenal Disorders. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-101-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-101-5_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-029-8
Online ISBN: 978-1-59259-101-5
eBook Packages: Springer Book Archive